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ABSTRACT
Skin-bleaching practices, such as using skin
creams and soaps to achieve a lighter skin
tone, are common throughout the world and
are triggered by cosmetic reasons that
oftentimes have deep historical, economic,
sociocultural, and psychosocial roots. Exposure
to chemicals in the bleaching products,
notably, mercury (Hg), hydroquinone, and
steroids, has been associated with a variety of
adverse health effects, such as Hg poisoning and
exogenous ochronosis. In New York City (NYC),
skin care product use has been identified as an
important route of Hg exposure, especially
among Caribbean-born blacks and
Dominicans. However, surprisingly sparse
information is available on the epidemiology
of the health impacts of skin-bleaching
practices among these populations. We
highlight the dearth of large-scale,
comprehensive, community-based, clinical,
and translational research in this area,
especially the limited skin-bleaching-related
research among non-White populations in the
US. We offer five new research directions,
including investigating the known and
under-studied health consequences among
populations for which the skin bleach practice
is newly emerging at an alarming rate using
innovative laboratory and statistical methods.
We call for conducting methodologically
rigorous, multidisciplinary, and culturally
sensitive research in order to provide insights
into the root and the epidemiological status of
the practice and provide evidence of
exposure-outcome associations, with an
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ultimate goal of developing potential
intervention strategies to reduce the health
burdens of skin-bleaching practice.
Keywords: Clinical research; Dermatology;
Environmental health; Skin bleaching; Skin of
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CURRENT CONTEXT
Skin-bleaching practices, such as using
skin-lightening creams and soaps to achieve a
lighter skin tone or to ‘‘whiten’’ skin, are
common among non-White populations
throughout the world, triggered by deep
historical, economic, sociocultural, and
psychosocial roots [1–5]. The exact prevalence
of this practice among different population
groups across different geographic areas is not
known, and the existing estimates (e.g.,
25–67%) have most likely been
underestimated, since some women may be
reluctant to admit the practice because of the
stigma surrounding these complexion-altering
behaviors [6, 7]. In addition, skin bleaching is
becoming more common among men and
young adults, including teenagers [3, 5, 8].
Prenatal exposure is also likely since pregnant
women have been reportedly using
skin-bleaching products [9, 10]. While
skin-bleaching research has been heavily
focused on darker-skinned African
populations, it has become an increasing
concern in Jamaica and other Afro-Caribbean
countries [6, 8, 11]. More specifically, Hope [5]
has posited that for Jamaicans, skin-bleaching
practices have transitioned from historically
being a response to economic and
complexion-related oppression of the
darker-skinned working class and poor
populations to a current expression of
‘‘…fashion and ungendered rites of beauty.’’
Skin bleaching has been associated with a
variety of known adverse health effects ranging
from dermatitis to exogenous ochronosis
(Fig. 1), steroid acne (Fig. 2), mercury (Hg)
poisoning, and nephrotic syndrome, which are
linked to ingredients such as hydroquinone,
corticosteroids, and Hg [1, 4, 6, 12–18]. Due to
health concerns, some of these chemicals are
regulated [19–23]. However, studies have found
products containing the aforementioned
ingredients with above legal limits, including
products from the USA and European Union,
where regulations are stricter and better
implemented. In addition, access to a variety
of legal and illegal skin-bleaching products—
including prescription strength hydroquinone
and topical corticosteroids—is made easy
through online purchases, global travel, and
immigration [17, 18, 24–26].
Fig. 1 Exogenous ochronosis on the face of a woman
with a history of hydroquinone use
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Skin bleaching is not uncommon in the US,
and the health burden of skin-bleaching
practices is not evenly distributed among the
population. The 2004 New York City (NYC)
local health and nutrition examination survey
identified skin care product use as an important
route of Hg exposure, especially among
Caribbean-born blacks and Dominicans in
NYC, with mean urine Hg concentrations
1.3–2.1 times higher than that of whites and
other racial/ethnic groups [26]. Despite these
reports, surprisingly sparse epidemiological
studies are available regarding the health
impacts of skin-bleaching practices on
Afro-Caribbean immigrant groups in the US.
In fact, this topic has gained very little attention
among clinical and translational researchers in
the US, with existing studies primarily limited
to investigations of outbreaks of Hg poisoning
related to the use of skin-whitening products
[27–29].
NEW DIRECTIONS
Thus, we have proposed five new directions for
research in this area. First, we must
comprehensively estimate the prevalence of
skin bleaching among both previously studied
populations and populations, like those from
Afro-Caribbean countries such as Jamaica, for
which this practice is newly emerging at an
alarming rate. While it is easier to focus just on
newly emerging populations by geography, we
should also examine the prevalence of this
practice among other under-studied risk
groups such as men, younger populations, and
pregnant mothers.
Second, besides the known dermatologic
effects of skin bleach, such as dermatitis,
exogenous ochronosis, and acne, we should
also expand our focus to long-term health
consequences such as cancer as well as
interactions between physical and
psychosocial health outcomes. The potential
carcinogenic effects of this practice may not be
solely limited to exposure to hydroquinone, a
primary metabolite of benzene, which is not
currently classified as carcinogenic to humans
because of conflicting results, though recent
evidence suggests that hydroquinone can
generate DNA damages and
immunosuppressive responses [18, 25, 26,
30–34]. Attention should also be given to
potential increased susceptibility to skin
cancer resulting from alterations of melanin
production among those who practice skin
bleaching, especially among populations living
in tropical regions with strong UV radiation.
While their darker skin is considered to be
protective of sun-induced skin cancer, the
carcinogenic effect of melanogenesis
inhibition resulting from skin bleaching
remains to be explored [35, 36].
Third, we should identify all skin-bleaching
products used and scientifically evaluate
ingredients such as metals, hydroquinone, and
the steroid composition of these exposures
using specialized laboratory methods [37, 38].
Most existing studies focus on only one of the
Fig. 2 Steroid acne on the chest following use of a
corticosteroid containing bleaching cream for over 1 year
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ingredients in these beauty products, which has
hindered investigations of the health effects of
exposure to mixtures from multiple ingredients.
In addition, because self-mixing of a variety of
chemicals (e.g., combining multiple
commercial skin-bleaching products with
hydrogen peroxide) is not uncommon,
investigations of harmful chemical
compositions in these home-made products
should also be considered.
Fourth, we should empirically compute the
dose-response relationships between the
aforementioned exposures and associated
dermatologic outcomes across various usage
patterns and durations, which also require
using innovative biomarkers to assess short-
and long-term exposures to skin-bleaching
products.
Last, but not the least, we posit that an
integrative approach that brings together a
multidisciplinary team of experts in
dermatology, environmental epidemiology,
biostatistics, pharmacology, behavioral
psychology, and community health will be
best suited to tackle this complex public
health problem. This would allow for a
large-scale, methodologically rigorous
approach that can simultaneously explore the
psychosocial motivations underlying this
practice, the toxicological risks, and causal
relationships between skin-bleaching
product-related exposures and health
outcomes. Existing studies often employ a
single-aspect design highlighting only one of
three topic areas: (1) psychosocial implications,
(2) dermatological health effects, or (3) an
exposure assessment of the skin-bleaching
practice. A well-designed, comprehensive
integrative study would give researchers the
latitude to investigate the underlying roots and
epidemiologic status of skin bleaching while
simultaneously providing evidence of
exposure-outcome associations, which would
serve as a necessary strategy if our ultimate goal
is to develop efficacious interventions that can
effectively reduce the health burdens of this
practice.
However, we understand that this
interdisciplinary undertaking is challenging,
given many in these communities, as we have
observed at our institution, may not associate
skin-related changes to their skin-bleaching
practices. Limited access to dermatologists
among the population at risk may also
contribute to under-detection of complications
of skin bleaching. Moreover, the underlying
stigma surrounding this behavior might prevent
these individuals from communicating their
concerns to clinicians whom they perceive to
have inadequate understanding of the cultural
context. While these are all challenges that we
must work on with these communities to
overcome, from a research perspective, we still
have a major difficulty in identifying patients
with specific diagnoses resulting from skin
bleaching because identifying cases requires an
index of suspicion on the part of the clinician
and specific inquiry into skin care practices,
which may not be performed consistently or
documented in the medical record [14].
CONCLUSION
In summary, if we are to adequately care for
clinically vulnerable, skin-bleaching
subpopulations of the African and
Afro-Caribbean immigrant communities, and
other under-studied populations in the US, we
must first understand the magnitude of the
problem, draw valid causal inference about the
harmful exposures from the skin-bleaching
products and their resulting health problems,
and subsequently provide culturally sensitive
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solutions that do not further stigmatize these
populations. This is especially important since
skin bleaching may be a rational response to
being born in racially and economically
segregated societies, even if this practice may
be viewed less favorably in the clinical and
translational sector.
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